Skip to main content
NIH funding notice RFA-AG-25-010

Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required)

Closed on October 17, 2024.

Posted
July 1, 2024
Close date
October 17, 2024
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
2
2 new
Median first-year cost
$4,270,065
$8,540,130 in all
Institutions
2
2 contact PIs

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. BRIGHAM AND WOMEN'S HOSPITAL1
  2. MEDICAL UNIVERSITY OF SOUTH CAROLINA1

Most frequent study sections

  1. Special Emphasis Panel (ZAG1 ZIJ-D (M1))2
2 awards under RFA-AG-25-010 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2025The Ante-Amyloid Treatment of Alzheimer's disease (A3) Trial and Alzheimer Plasma EXtension (APEX) Study1R01AG095009-01Aisen, Paul S.Johnson, Keith A.Molina-Henry, Doris PatriciaSperling, Reisa A.BRIGHAM AND WOMEN'S HOSPITAL, MAFirst-year cost $6,467,513Study section ZAG1
FY2025Life’s end Benefits of CannaBidiol and TetrahYdrocannabinol (LiBBY) Open-Label Extension (OLE) Study1R01AG095004-01Aisen, Paul S.Brawman-Mintzer, OlgaMintzer, JacoboRafii, Michael SReynolds, BrigidMEDICAL UNIVERSITY OF SOUTH CAROLINA, SCFirst-year cost $2,072,617Study section ZAG1
Newest fiscal year first, then first-year cost.

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-13-0.3.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.